Mode
Text Size
Log in / Sign up

Pathologic features predict rapid recurrence in T1 melanoma patients across 14 sites.

Pathologic features predict rapid recurrence in T1 melanoma patients across 14 sites.
Photo by Bioscience Image Library by Fayette Reynolds / Unsplash
Key Takeaway
Note that specific pathologic features associate with rapid recurrence in T1 melanoma, but causality is unproven.

This observational study examined clinical and pathological characteristics of 442 patients with T1 melanoma recruited from 14 sites. The analysis compared patients with rapid recurrence against a comparator group with late recurrence (defined as recurrence >=10 years) to identify associated risk factors. No intervention was applied as this was a retrospective comparison of existing patient data.

Significant positive associations were identified for several variables. Age greater than 65 years showed a strong association with rapid recurrence (p<0.0001 univariable; p=0.0010 multivariable). The lentigo maligna subtype was significantly associated with rapid recurrence (p=0.025 univariable). Primary tumors located on the head or neck also demonstrated a significant association (p=0.0065 univariable). Histological features including mitoses >=1/mm2 (p=0.0181 univariable; p=0.049 multivariable) and ulceration (p=0.0087 univariable; p=0.037 multivariable) were linked to rapid recurrence.

Regarding recurrence patterns, the majority (73%) of recurrences in the rapid group were locoregional. No safety data, adverse events, or discontinuations were reported, as no treatment intervention was evaluated. The study explicitly notes that causality is not claimed and that these findings describe associations using logistic regression analysis.

Key limitations include the observational nature of the design, which precludes causal inference. The clinical significance of these surrogate markers without direct clinical outcome data should not be overstated. These findings may assist in identifying high-risk T1 melanomas but require validation in prospective cohorts before altering management guidelines.

Study Details

Sample sizen = 442
EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
Background: Although thin, T1 melanomas have an excellent cure rate with surgery alone, >25% of melanoma deaths originate from thin melanomas (TMs). There is, therefore, an urgent need to improve the identification and management of patients with TMs at high risk of recurrence. Methods: Patients with T1 melanoma and recurrence [&le;] 2 years of diagnosis (T1 rapid group) were compared to patients with T1 melanoma and recurrence [&ge;]10 years after diagnosis (T1 late group). Results: 442 patients from 14 sites were included: 310 and 132 patients in the T1 rapid and late groups, respectively. Median age at primary melanoma diagnosis was 51 years [15-85], 272 (62%) male, 254 (58%) superficial spreading and 101 (23%) head/neck primary. The majority (73%) of recurrences in the T1 rapid group were locoregional. Using univariable logistic regression analysis, age >65 years (p<0.0001), lentigo maligna (LM) melanoma subtype (p=0.025), head/neck primary site (p=0.0065), mitoses [&ge;]1/mm2 (p=0.0181) and ulceration (p=0.0087) were significantly associated with T1 rapid recurrence compared to T1 late recurrence. Using multivariable analysis, age >65 years (p=0.0010), mitoses [&ge;]1/mm2 (p=0.049) and ulceration (p=0.037) remained significant. Conclusions: Rapid recurrence of TM is associated with age >65 years, LM subtype, head/neck primary site, mitoses [&ge;]1/mm2 and ulceration.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.